← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Jsk Therapeutics, Inc.
Sandy, UT
$3,188,728
Total funding
2
Grants
Funding over time
peak $999.4K · FY2010–18$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,188,728 · 2
By mechanism
R44$3,188,728 · 2
Investigators at Jsk Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Clinical Development of JS-K for the Treatment of Cancer$999,423
R44 · FY2018 · CA
Clinical Development of JS-K for the Treatment of Cancer$999,183
R44 · FY2017 · CA
Preclinical Development of JS-K, a Novel NO-Generating Prodrug for Cancer$927,566
R44 · FY2012 · CA
Preclinical Development of JS-K, a Novel NO-Generating Prodrug for Cancer$142,814
R44 · FY2014 · CA
Preclinical Development of JS-K, a Novel NO-Generating Prodrug for Cancer$119,742
R44 · FY2010 · CA